All In MedTech

FDA Clearance Tracker · P890023-S014

HYDROGENICS 60 (OCUFILCON F) UV IMT SOFT (HYDROPHILIC) CONTACT LENS FOR EXTENDED WEAR

A PMA supplement is a change to a device that already has premarket approval, such as a new indication, a design change or a manufacturing change.

Last checked: Nov 20, 2026Latest source record: Jan 14, 2004 (this decision)Source: openFDAMethods & limitations

PMA supplement

Decided

Jan 14, 2004

Approved

Time to decision

23 days

Received Dec 22, 2003. Calendar days, including time FDA spent waiting on the applicant.

Pathway

PMA supplement

Normal 180 Day Track No User Fee

Device class

Class III

The decision

FDA number
P890023-S014
Device name
HYDROGENICS 60 (OCUFILCON F) UV IMT SOFT (HYDROPHILIC) CONTACT LENS FOR EXTENDED WEAR
Applicant location
Pleasanton, CA
Received
Dec 22, 2003
Decided
Jan 14, 2004
Decision
Approved
Supplement type
Normal 180 Day Track No User Fee
Reason for supplement
Express GMP Supplement
Original approval
P890023

Device type

Device class
Class III
Regulation
21 CFR 886.5925
Specialty
Ophthalmology

Every decision under product code LPM

FDA's approval statement

As written in FDA's record.

APPROVAL FOR MANUFACTURING SITES LOCATED AT OCULAR SCIENCES PUERTO RICO IN JUANA DIAZ, PUERTO RICO AND SANTA ISABEL, PUERTO RICO.

Source documents

Other decisions for The Cooper Companies

Matched on the applicant name as FDA recorded it. A company that files under several names will have more.

Company page

No other decisions since 2015 under this exact applicant name.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.